Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Liminal Biosciences (LMNL)

Annual Return

Over the past 3 years, LMNL has had an average annual return of +1.67%, outperforming the benchmark SPY, which returned -6.17% annual.

Over the past 5 years, LMNL has had an average annual return of -46.32%, underperforming the benchmark SPY, which returned -0.04% annual.

Since Nov 18, 2019, LMNL has had an average annual return of -40.62%, underperforming the benchmark SPY, which returned +10.22% annual.

20232022202120202019
+161.52%-70.18%-74.04%-49.88%+31.97%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2023+32.23%+33.09%-33.63%+78.60%-2.25%-5.27%+33.47%+0.30%+1.13%+161.52%
2022-16.66%-3.14%+12.48%-22.90%-31.86%-1.47%-18.96%+18.04%-14.38%+26.32%-18.92%-24.37%-70.18%
2021+9.06%+4.80%-13.96%+21.79%-12.12%-12.00%-24.68%-11.27%-11.14%-25.98%-25.14%-14.83%-74.04%
2020+16.94%-15.80%-18.97%+21.30%+27.49%+4.45%+51.02%-30.10%-2.37%-58.67%-13.27%+5.27%-49.88%
2019-8.72%+44.58%+31.97%

Drawdown analysis of Liminal Biosciences (LMNL)

The maximum drawdown for the LMNL was -98.63%, occurring on Dec 30, 2022. This drawdown has not yet recovered.

The current LMNL drawdown is -96.43%.

Since Nov 18, 2019 LMNL has experienced the following drawdowns:

  • 50% or more: 3 times
  • 40% or more: 3 times
  • 30% or more: 3 times
  • 20% or more: 4 times
  • 10% or more: 5 times
DepthStartTo BottomBottomTo RecoverEndTotal
-98.63%Jul 30, 2020610Dec 30, 2022OngoingOngoingOngoing
-58.24%Jan 10, 202046Mar 18, 202073Jul 1, 2020119
-53.31%Jul 1, 202019Jul 29, 20201Jul 30, 202020
-26.01%Dec 23, 20195Dec 31, 20196Jan 9, 202011
-12.77%Nov 20, 201910Dec 5, 201912Dec 23, 201922
-0.30%Nov 18, 20191Nov 19, 20191Nov 20, 20192